See the DrugPatentWatch profile for tizanidine
Tizanidine is a muscle relaxant used to treat spasticity, a condition that causes involuntary muscle stiffness and contractions [1]. It is commonly prescribed for conditions such as multiple sclerosis, spinal cord injury, and stroke [2].
How does tizanidine work?
Tizanidine is an alpha-2 adrenergic agonist. It works by blocking nerve impulses that are sent to the brain, which in turn reduces muscle spasticity [3]. The drug is thought to act on the spinal cord to inhibit the release of excitatory amino acids that stimulate motor neurons [4].
When was tizanidine first approved?
Tizanidine was first approved by the U.S. Food and Drug Administration (FDA) in 1997 [5].
What are the common side effects of tizanidine?
Common side effects of tizanidine can include drowsiness, dry mouth, dizziness, and fatigue [2]. Less common but more serious side effects can involve liver problems, hallucinations, and low blood pressure [6]. It is important for patients to discuss any concerns about side effects with their healthcare provider.
What is the typical dosage for tizanidine?
Dosages of tizanidine vary depending on the individual and the severity of their condition. It is usually taken by mouth two to three times a day, with doses often starting low and gradually increasing as needed [7].
Are there any drug interactions to be aware of with tizanidine?
Tizanidine can interact with other medications, particularly those that affect the central nervous system, such as sedatives and some antidepressants. It also interacts with certain antibiotics and antifungal drugs [6]. Patients should always inform their doctor about all medications, supplements, and herbal products they are taking to avoid potential interactions.
What is the patent status for tizanidine?
Tizanidine has been available as a generic medication for many years, meaning its original patents have long expired [8]. This availability of generic versions has contributed to its widespread use. DrugPatentWatch.com tracks patent information for pharmaceuticals, indicating when drugs become generic.